(Rac)-Minzasolmin is an alpha-synuclein (ASYN) misfolding inhibitor that effectively penetrates the blood-brain barrier. By targeting the early stages of ASYN aggregation, (Rac)-Minzasolmin promotes the reversion of membrane-bound oligomers back to their monomeric form, thereby preventing pathological aggregation. This compound has demonstrated efficacy in reducing ASYN deposition in the retina and improving neuro-pathological indicators in two α-synuclein transgenic mouse models. It is a valuable tool for research on Parkinson's disease and dementia with Lewy bodies.
(Rac)-Minzasolmin is an alpha-synuclein (ASYN) misfolding inhibitor that effectively penetrates the blood-brain barrier. By targeting the early stages of ASYN aggregation, (Rac)-Minzasolmin promotes the reversion of membrane-bound oligomers back to their monomeric form, thereby preventing pathological aggregation. This compound has demonstrated efficacy in reducing ASYN deposition in the retina and improving neuro-pathological indicators in two α-synuclein transgenic mouse models. It is a valuable tool for research on Parkinson's disease and dementia with Lewy bodies.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
